Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are unusual in this malignancy when compared to other lymphoid neoplasms. CHD2 is mutated in 5% of CLL and 7% of MBL.75 The histone methyltransferase SETD2 and ARID1A will also be mutated in a little proportion of people. Of note, MYD88 mutations a